Professor Jim Denham from Calvary Mater Newcastle and the University of Newcastle is conducting groundbreaking research for better treatments to address the high prostate cancer death rate in the Hunter region.
Researchers and support services in Newcastle joined forces in 2009, co-locating the Hunter Prostate Cancer Alliance and TROG prostate cancer trials team.
The Centre focuses on research, treatment, and public awareness of prostate cancer. Researchers found that the time between treatment for prostate cancer and a subsequent rise in the blood PSA level, together with the rate at which it then rises, are measures that can be used to predict who needs new and more effective treatments. This will also predict the results of large scale trials five to ten years earlier than previously thought possible.